SCHEMBL3763009

SCHEMBL3763009

C=CCCCCOc1cccc(CN)c1F

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 5/20 0.39
RPS6KA1 Q15418 1/20 0.35
L3MBTL1 Q9Y468 4/20 0.34
TDP1 Q9NUW8 2/20 0.34
HTR1B P28222 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 2/20 0.33
USP2 O75604 2/20 0.33
PPARG P37231 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KMT2A Q03164 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759944 0.98 KDM4E (0.38) KDM4EALDH1A1RPS6KA1L3MBTL1TDP1
SCHEMBL3766502 0.98 KDM4E (0.38) KDM4EALDH1A1RPS6KA1L3MBTL1TDP1
SCHEMBL3765885 0.95 KDM4E (0.40) KDM4EALDH1A1RPS6KA1L3MBTL1HTR1B
SCHEMBL3764285 0.91 KDM4E (0.48) KDM4EALDH1A1RPS6KA1L3MBTL1HTR1B
SCHEMBL31267901 0.83 L3MBTL1 (0.44) KDM4EALDH1A1L3MBTL1TDP1MAPT
SCHEMBL3766281 0.82 L3MBTL1 (0.36) KDM4EALDH1A1RPS6KA1L3MBTL1TDP1
SCHEMBL9699978 0.81 L3MBTL1 (0.42) KDM4EALDH1A1L3MBTL1TDP1MAPT
SCHEMBL9710295 0.81 L3MBTL1 (0.42) KDM4EALDH1A1L3MBTL1TDP1MAPT
SCHEMBL3770673 0.81 L3MBTL1 (0.35) KDM4EALDH1A1RPS6KA1L3MBTL1TDP1
SCHEMBL3770876 0.81 L3MBTL1 (0.38) RPS6KA1L3MBTL1TDP1HTR1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 KDM4E 2021/4885ALDH1A1 2906/4885RPS6KA1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.